Articles

The stock of Ascendis Pharma A/S jumped 11% early Monday, after the biotech said the U.S. Food and Drug Administration has approved its Yorvipath as the first and only treatment for a rare endocrine disease.

WeRide plans to trade on the Nasdaq under the symbol WRD.

A group of trend-following investors active in futures markets has pared its bets against the Japanese yen by the widest margin in years, according to the latest data from the Commodity Futures Trading Commission.

Pfizer plans to share the findings at a scientific conference and publish them in a peer-reviewed scientific journal. The company will also submit the data to regulatory agencies for review.

Marathon Digital’s stock took a hit Monday, after the cryptocurrency miner announced plans for a $250 million debt offering, that could be converted into common stock.

Crude futures rose Monday, holding on to solid gains after the Organization of the Petroleum Exporting Countries trimmed its forecast for growth in oil demand due to softness in China.

A replay of the 1920s bull market would be something to celebrate. But hold the Champagne.

Yen carry-trade shows how the U.S. dollar makes trouble for the world.

‘Incredible values’ can be found beyond the Magnificent Seven when you broaden your horizon.

Canada’s Bank of Nova Scotia said the deal will grow its presence in the U.S.

Stocks have bigger problems than the yen carry trade says Morgan Stanley’s Mike Wilson

“I’m giving everything to my two adult children equally, although I doubt they’ll keep anything.”